BMS-986405

Overview

BMS-986405 is a small molecule Gamma-Secretase Inhibitor being investigated in clinical trials in patients with T-cell acute lymphoblastic leukemia, T-cell lymphoblastic lymphoma and multiple myeloma.

SparkCures ID 313
Developed By Eli Lilly and Company
Generic Name BMS-986405
Additional Names LY3039478, JSMD194
Treatment Classifications
  • Gamma-Secretase Inhibitor

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.